Navigation Links
LifeCare Holdings, Inc. Announces Third Quarter Results
Date:11/14/2007

10

Number of total hospitals

(end of period) 19 19

Licensed beds (end of period) 894 1,008

Average licensed beds (1) 884 944

Admissions 6,219 5,868

Patient days 170,453 172,042

Occupancy rate 70.6% 66.8%

Percent net patient service

revenue from Medicare 71.5% 64.3%

Percent net patient service

revenue from commercial

payors and Medicaid (2) 28.5% 35.7%

Net patient service revenue

per patient day $1,443 $1,409

(1) The licensed beds are only calculated on the beds at locations that

were open for operations during the applicable period, and exclude beds at

locations prior to openings, or subsequent to closures.

(2) The percentage of net patient service revenue from Medicaid is less

than one percent for each of the periods presented.


'/>"/>
SOURCE LifeCare Holdings, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related medicine news :

1. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
2. AHPC Holdings, Inc. Announces Intent to Deregister Common Stock With Securities and Exchange
3. Siemens Announces Early Termination of Hart-Scott-Rodino Waiting Period For Acquisition of Dade Behring Holdings, Inc.; U.S. Antitrust Clearance Achieved
4. Platinum Underwriters Holdings, Ltd. to Report Third Quarter 2007 Results on October 23, 2007
5. Air Methods Completes Acquisition of FSS Airholdings, Inc., Parent Company of CJ Systems Aviation Group, Inc.
6. NightHawk Radiology Holdings, Inc. Announces Date for Third Quarter Earnings Conference Call
7. China Shenghuo Pharmaceutical Holdings, Inc. Opens Showcase 12Ways(R) Chinese Herbal Beauty Salon in October
8. NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results
9. Duane Reade Holdings, Inc. to Report Third Quarter 2007 Financial Results
10. China Holdings, Inc. Announces 2nd Biomass Renewable Energy Project (Power Capacity: 50 MW); Total Potential: 100 MW in Biomass Energy Pipeline
11. Statement by Bonnie J. Campbell, Former Attorney General of Iowa and Spokesperson for Atlantic Richfield Co., Millennium Holdings, LLC, NL Industries, Inc., and The Sherwin-Williams Company on the Jury Verdict Reached Today in the Thomas (Milwaukee) Case
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2008)... in progression of risk factors as subjects aged ,...New insights into lung disease and lung function i..., The researchers analyzed data from the U.S. Nat...oronary Artery Risk Development in Young Adults) o...ears of health assessments in more than 5,000 youn...
(Date:5/22/2008)...illion Americans whove received drug-eluting stent...right future, according to new research from the U...The findings, among the first large follow-up stud...uting stents compared to bare metal stents, will b...the American College of Cardiology. Patients with ...
(Date:5/22/2008)...ozed at wheel; National Road Safety Fou...W YORK, May 22 /PRNewswire/ -- As people jam the r...hich marks the start of the peak summer,driving se...into -- a,drowsy driver, says the National Road Sa...vides free driver safety films and programs includ...
(Date:5/22/2008)...ewswire/ -- Many baby boomers,incorrectly believe ...to a,new survey conducted by Harris Interactive(R)...IP). Most say that disability insurance is importa...ey do not have any disability,income protection., ...830/AHIPLOGO ), "Baby boomers recognize the valu...
Breaking Medicine News(10 mins):Health News:CARDIA Studies Open Window on Heart, Lung Diseases 2Health News:CARDIA Studies Open Window on Heart, Lung Diseases 3Health News:More patients with drug-coated cardiac stents survive, avoid costly follow-up procedures 2Health News:Drowsy Driving as Dangerous as Drunk Driving 2Health News:Many Baby Boomers Incorrectly Believe They Are Protected Against the Risk of Disability 2Health News:Many Baby Boomers Incorrectly Believe They Are Protected Against the Risk of Disability 3
...ernational research consortium investigating the g...s has identified a new genetic risk factor for coe...fering from coeliac disease lack a protective DNA ...n, otherwise found in healthy individuals. Behind...
...ing to a research abstract that will be presented ...sorder among infants and toddlers born prematurel... and at higher rates than among full-term infants....ontgomery-Downs, PhD, of West Virginia University,...
...orts are to be believed, then the "medical conditi...jail early, only to be thrown back inside a day l...ed infection. According to the News of the World ...I, and it is such a "severe problem" that Sheriff ...
...ocumented first -of -its-kind case, a teenager die...he aching muscles. Arielle Newman, 17, from Stat... surprisingly high amount of methyl salicylate, th...eams, was discovered in her body. Various compan...
Other Medicine News:Health News:Genetic Risk Factor for Coeliac Disease Identified. 2Health News:Paris' 'medical Condition' is a Sexually Transmitted Infection 2Health News:American Sports Star Teenager Dies Due To Overdose Of Muscle Cream 2
(Date:5/22/2008)...didate, RDEA806, Demonstrated No Reproductive Toxi... -, - RDEA427 Selected as Clinical Candidate, Demo...ential for Once Daily Oral Dosing -, SAN DIEGO, M... Inc.,(Nasdaq: RDEA ) today announced preclinical...tase inhibitor (NNRTI) candidate, RDEA806, demonst...
(Date:5/21/2008)...derscore the Utility of CAPHOSOL in Treating Oral ...- New data show that CAPHOSOL(R), (http://www.caph...eves painful oral,mucositis (OM) and improves qual...erapy and radiation therapy. These data were repor... 33rd Annual Congress of the,Oncology Nursing Soci...
(Date:5/21/2008)...nted at 12th World Congress on the Menopause show ...yspareunia, two of the most frequent s... ARBOR, Mich., May 21 /- QuatRx Pharm...rom a pivotal Phase 3 study of Ophena(TM),(ospemif...mptoms of,vulvovaginal atrophy, a common condition...
(Date:5/21/2008)...EIGHTS, N.J., May 21 /- Gen...ed that multiple abstracts,featuring its lead onco...meeting of the American Society of Clinical Oncolo...he abstracts include the following:, -- Initial ... G4544, an oral gallium-containing Compound. ...
Breaking Medicine Technology:Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program 2Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program 3Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program 4CAPHOSOL(R) Relieves Oral Mucositis (OM) and Improves Quality-of-Life in Cancer Patients Receiving Chemoradiation 2CAPHOSOL(R) Relieves Oral Mucositis (OM) and Improves Quality-of-Life in Cancer Patients Receiving Chemoradiation 3CAPHOSOL(R) Relieves Oral Mucositis (OM) and Improves Quality-of-Life in Cancer Patients Receiving Chemoradiation 4CAPHOSOL(R) Relieves Oral Mucositis (OM) and Improves Quality-of-Life in Cancer Patients Receiving Chemoradiation 5CAPHOSOL(R) Relieves Oral Mucositis (OM) and Improves Quality-of-Life in Cancer Patients Receiving Chemoradiation 6QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena(TM) (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy 2QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena(TM) (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy 3Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology 2Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology 3FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE 28TM 29 28lisdexamfetamine dimesylate 29 Which May Help Physicians Tailor T 2429 1FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE 28TM 29 28lisdexamfetamine dimesylate 29 Which May Help Physicians Tailor T 2429 2FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE 28TM 29 28lisdexamfetamine dimesylate 29 Which May Help Physicians Tailor T 2429 3FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE 28TM 29 28lisdexamfetamine dimesylate 29 Which May Help Physicians Tailor T 2429 4FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE 28TM 29 28lisdexamfetamine dimesylate 29 Which May Help Physicians Tailor T 2429 5QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena 28TM 29 28ospemifene 29 to Treat Postmenopausal Vaginal Syndrome 1131 1QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena 28TM 29 28ospemifene 29 to Treat Postmenopausal Vaginal Syndrome 1131 2QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena 28TM 29 28ospemifene 29 to Treat Postmenopausal Vaginal Syndrome 1131 3Hookah Smoking as Tough on Lungs as Cigarettes 9019 1Hookah Smoking as Tough on Lungs as Cigarettes 9019 2Hookah Smoking as Tough on Lungs as Cigarettes 9019 3Novel anticancer strategy moves from laboratory to clinic 9014 1Novel anticancer strategy moves from laboratory to clinic 9014 2Novel anticancer strategy moves from laboratory to clinic 9014 3
...in Key Lung Compartments, REINACH and BASEL, Switz...rpida Ltd. today announced promising,results of "f...led,Human Microdose studies included a total of 19...udy is the first ever using Microdosing,for the de...ments.,The results showed that AR-709 achieves hig...
...Mar 29, 2007 - ACADIA Pharmaceuticals,Inc. (Nasdaq...ovative technology to fuel drug discovery and clin...ervous system,disorders, today announced that the ...gress on Schizophrenia Research, held from,March 2...rado.,Presentations will cover ACADIA,s two schizo...
Other Medicine Technology:Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 2Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 3Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 4Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 5ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at,the 2007 International Congress on Schizophrenia Research 2ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at,the 2007 International Congress on Schizophrenia Research 3ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at,the 2007 International Congress on Schizophrenia Research 4ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at,the 2007 International Congress on Schizophrenia Research 5
Volk's super series slit lamp biomicroscopy lenses. General retinal scanning situations. Provide unprecedented fundus diagnostic capability, specifically addressing maximum potential field of view, f
Volk indirect lenses. High magnification views of the posterior pole.
Precision has its new line of programmable autoclaves which are easy to use bench-top autoclaves or models to fit any need. It has 4 adjustable sterilization programs, touch button control panel, man
...ina Tomograph is a confocal laser scanning microsc...nal images of the posterior segment. It enables th...y and precise follow-up of topographic changes. Th...eidelberg Retina Tomograph is the topographic desc...
Medicine Products: